Graft coronary vasculopathy in cardiac transplantation--evaluation of risk factors by multivariate analysis

Wahlers, T; Fieguth, H G; Jurmann, M; Albes, J; Hausen, B; Demertzis, S; Schäfers, H J; Oppelt, P; Mügge, A; Borst, H G (1996). Graft coronary vasculopathy in cardiac transplantation--evaluation of risk factors by multivariate analysis. European journal of cardio-thoracic surgery, 1(10), pp. 1-5. Oxford: Oxford University Press 10.1016/S1010-7940(96)80258-2

Full text not available from this repository. (Request a copy)

The development of coronary vasculopathy is the main determinant of long-term survival in cardiac transplantation. The identification of risk factors, therefore, seems necessary in order to identify possible treatment strategies. Ninety-five out of 397 patients, undergoing orthotopic cardiac transplantation from 10/1985 to 10/1992 were evaluated retrospectively on the basis of perioperative and postoperative variables including age, sex, diagnosis, previous operations, renal function, cholesterol levels, dosage of immunosuppressive drugs (cyclosporin A, azathioprine, steroids), incidence of rejection, treatment with calcium channel blockers at 3, 6, 12, and 18 months postoperatively. Coronary vasculopathy was assessed by annual angiography at 1 and 2 years postoperatively. After univariate analysis, data were evaluated by stepwise multiple logistic regression analysis. Coronary vasculopathy was assessed in 15 patients at 1 (16%), and in 23 patients (24%) at 2, years. On multivariate analysis, previous operations and the incidence of rejections were identified as significant risk factors (P < 0.05), whereas the underlying diagnosis had borderline significance (P = 0.058) for the development of graft coronary vasculopathy. In contrast, all other variables were not significant in our subset of patients investigated. We therefore conclude that the development of coronary vasculopathy in cardiac transplant patients mainly depends on the rejection process itself, aside from patient-dependent factors. Therapeutic measures, such as the administration of calcium channel blockers and regulation of lipid disorders, may therefore only reduce the progress of native atherosclerotic disease in the posttransplant setting.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Faculty Institutions > Teaching Staff, Faculty of Medicine

UniBE Contributor:

Demertzis, Stefanos






Oxford University Press




Factscience Import

Date Deposited:

04 Oct 2013 15:08

Last Modified:

06 Dec 2013 13:56

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 157838)

Actions (login required)

Edit item Edit item
Provide Feedback